Watanabe Y, Matsumiya T, Oka T
Tokai J Exp Clin Med. 1981 Oct;6(4):443-51.
It has been demonstrated that most hypertensive drugs which cause increases in levels of norepinephrine influence the stimulation of monosynaptic reflex (MSR) neural activity. However this report discusses the effects of a hypotensive drug, which causes decreases in levels of norepinephrine, on the MSR amplitude of acute spinal cats. This drug is 5-butylpicolinic acid (fusaric acid: FA) which is an effective hypotensive agent and a potent inhibitor of dopamine beta-hydroxylase (approximately 10 times more potent than disurfiram). Intravenous injections of FA increased MSR neural activity in a dose-dependent manner. The FA-induced neural activity was gradually depressed by treatment with haloperidol, a dopamine and/or a alpha receptor blocker and methysergide, a serotonin receptor blocker, respectively. In addition, this neural activity was potentiated by the sequential administration of L-dopa. FA did not cause increases in the blood pressure but inhibit the synthesis of norepinephrine from dopamine. These results suggest that not only hypertensive but also hypotensive drugs can affect the increase of MSR neural activity, and dopamine plays an important role in FA-induced neural activity.
已经证明,大多数导致去甲肾上腺素水平升高的降压药物会影响单突触反射(MSR)神经活动的刺激。然而,本报告讨论了一种导致去甲肾上腺素水平降低的降压药物对急性脊髓猫MSR振幅的影响。这种药物是5-丁基吡啶甲酸(富马酸:FA),它是一种有效的降压剂,也是多巴胺β-羟化酶的强效抑制剂(效力约为双硫仑的10倍)。静脉注射FA以剂量依赖性方式增加MSR神经活动。FA诱导的神经活动分别被多巴胺和/或α受体阻滞剂氟哌啶醇和5-羟色胺受体阻滞剂麦角新碱治疗逐渐抑制。此外,这种神经活动通过依次给予左旋多巴而增强。FA不会导致血压升高,但会抑制多巴胺合成去甲肾上腺素。这些结果表明,不仅降压药而且降压药都可以影响MSR神经活动的增加,并且多巴胺在FA诱导的神经活动中起重要作用。